An Exploratory Study of JNS004 (Nesiritide) in Patients With Acute Heart Failure (J2).

Trial Profile

An Exploratory Study of JNS004 (Nesiritide) in Patients With Acute Heart Failure (J2).

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2014

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Acute heart failure
  • Focus Therapeutic Use
  • Sponsors Janssen Pharmaceutica
  • Most Recent Events

    • 29 Jan 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 29 Jan 2009.
    • 29 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 29 Jan 2009 Actual patient numbers (67) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top